China (Mainland)
Assessedsupplier
Irbesartan (Lrbesartan) CAS NO.138402-11-6
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T
- Product Details
Keywords
- Lrbesartan
- Irbesartan
- 144701-48-4
Quick Details
- ProName: Irbesartan (Lrbesartan)
- CasNo: 138402-11-6
- Molecular Formula: C25H28N6O
- Appearance: White to offwhite crystalline powder
- Application: anti-cancer agent
- DeliveryTime: depends on yr quantity
- PackAge: bottle/drum or customer's request
- Port: china mian port
- ProductionCapacity: 1 Metric Ton/Month
- Purity: 99%
- Storage: room tempertaure
- Transportation: by sea, air or express
- LimitNum: 1 Kilogram
- Related Substances: N/A
- Residue on Ignition: N/A
- Heavy Metal: N/A
- Valid Period: N/A
- TRANSPORTATION: N/A
Superiority
Irbesartan Basic information
| Antihypertensives Telmisartan Usage and Dosage Drug interaction Overdose Adverse reactions Chemical property Application Production Method |
| Product Name: | Irbesartan |
| Synonyms: | 3-butyl-2-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one;2-BUTYL-3-[[2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1,3-DIAZASPIRO[4.4]NON-1-EN-4-ONE;IRBESARTAN;BMS-186295;AVAPRO;APROVEL;SR-47436;Lrbesartan |
| CAS: | 138402-11-6 |
| MF: | C25H28N6O |
| MW: | 428.53 |
| EINECS: | |
| Product Categories: | Active Pharmaceutical Ingredients;Antihypertensive;Hypertension;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;API's;Aromatics;Heterocycles;Isotopically Labeled Pharmaceutical Reference Standard;LITAREX |
| Mol File: | 138402-11-6.mol |
|
|
|
Details
Irbesartan Chemical Properties
| mp | 180-181°C |
| storage temp. | -20°C Freezer |
| CAS DataBase Reference | 138402-11-6(CAS DataBase Reference) |
Usage
| An angiotensin II type 1 (AII1)-receptor antagonist | |
| Usage | antidepressant |
| Usage | For the treatment of hypertension, as well as diabetic nephropathy with an elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. Irbesartan is also used as a second line agent in the treatment of conges |
